home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

New Drug Target for Leukaemia

  June, 19 2009 8:03
your information resource in human molecular genetics

A genetic change in leukaemia cells that is essential to their proliferation, but also makes the cells vulnerable to an existing drug, has been identified in a paper online in Nature Genetics. The research highlights specific cells that could be used as drug targets in the treatment of certain types of leukaemia.

Shaoguang Li and colleagues used one particular mouse model of chronic myeloid leukaemia (CML) caused by a mutation called BCR-ABL that fuses together two normally separate genes just as it does in human leukaemia. They found that the mice with this mutation, but lacking a third gene, called Alox5, did not get the leukaemia.

Since drugs targeting Alox5 function have already been developed, the researchers tested one of these and found it prolonged the life of the mice with leukaemia, without impairing the production of normal blood cells. This research demonstrates that a strategy to target specifically the progenitor cells that initiate this leukemia, rather than the bulk of the cancer cells, is feasible.

Author contact:

Shaoguang Li (University of Massachusetts Medical School, Worcester, MA, USA)
E-mail: shaoguang.li@umassmed.edu

Abstract available online.

(C) Nature Genetics press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.